These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Genotype versus phenotype in families with androgen insensitivity syndrome. Boehmer AL; Brinkmann O; Brüggenwirth H; van Assendelft C; Otten BJ; Verleun-Mooijman MC; Niermeijer MF; Brunner HG; Rouwé CW; Waelkens JJ; Oostdijk W; Kleijer WJ; van der Kwast TH; de Vroede MA; Drop SL J Clin Endocrinol Metab; 2001 Sep; 86(9):4151-60. PubMed ID: 11549642 [TBL] [Abstract][Full Text] [Related]
4. [Androgen insensitivity syndrome. Clinical features and molecular genetics]. Sólyom J; Scheiber D; Fekete G Orv Hetil; 2001 Aug; 142(31):1659-65. PubMed ID: 11556259 [TBL] [Abstract][Full Text] [Related]
5. AR and SRD5A2 gene mutations in a series of 51 Turkish 46,XY DSD children with a clinical diagnosis of androgen insensitivity. Akcay T; Fernandez-Cancio M; Turan S; Güran T; Audi L; Bereket A Andrology; 2014 Jul; 2(4):572-8. PubMed ID: 24737579 [TBL] [Abstract][Full Text] [Related]
6. Molecular features and clinical phenotypes in androgen insensitivity syndrome in the absence and presence of androgen receptor gene mutations. Holterhus PM; Werner R; Hoppe U; Bassler J; Korsch E; Ranke MB; Dörr HG; Hiort O J Mol Med (Berl); 2005 Dec; 83(12):1005-13. PubMed ID: 16283146 [TBL] [Abstract][Full Text] [Related]
7. Androgen insensitivity syndrome: somatic mosaicism of the androgen receptor in seven families and consequences for sex assignment and genetic counseling. Köhler B; Lumbroso S; Leger J; Audran F; Grau ES; Kurtz F; Pinto G; Salerno M; Semitcheva T; Czernichow P; Sultan C J Clin Endocrinol Metab; 2005 Jan; 90(1):106-11. PubMed ID: 15522944 [TBL] [Abstract][Full Text] [Related]
8. Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome. Ahmed SF; Cheng A; Dovey L; Hawkins JR; Martin H; Rowland J; Shimura N; Tait AD; Hughes IA J Clin Endocrinol Metab; 2000 Feb; 85(2):658-65. PubMed ID: 10690872 [TBL] [Abstract][Full Text] [Related]
9. Partial androgen insensitivity syndrome due to somatic mosaicism of the androgen receptor. Batista RL; Rodrigues AS; Machado AZ; Nishi MY; Cunha FS; Silva RB; Costa EMF; Mendonca BB; Domenice S J Pediatr Endocrinol Metab; 2018 Jan; 31(2):223-228. PubMed ID: 29267169 [TBL] [Abstract][Full Text] [Related]
10. Phenotypic and molecular characteristics of androgen insensitivity syndrome patients. Yuan SM; Zhang YN; Du J; Li W; Tu CF; Meng LL; Lin G; Lu GX; Tan YQ Asian J Androl; 2018; 20(5):473-478. PubMed ID: 29785970 [TBL] [Abstract][Full Text] [Related]
11. Long-term followup and comparison between genotype and phenotype in 29 cases of complete androgen insensitivity syndrome. Cheikhelard A; Morel Y; Thibaud E; Lortat-Jacob S; Jaubert F; Polak M; Nihoul-Fekete C J Urol; 2008 Oct; 180(4):1496-501. PubMed ID: 18710728 [TBL] [Abstract][Full Text] [Related]
12. Phenotypic variation in a family with partial androgen insensitivity syndrome explained by differences in 5alpha dihydrotestosterone availability. Boehmer AL; Brinkmann AO; Nijman RM; Verleun-Mooijman MC; de Ruiter P; Niermeijer MF; Drop SL J Clin Endocrinol Metab; 2001 Mar; 86(3):1240-6. PubMed ID: 11238515 [TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular aspects of androgen insensitivity. Hiort O Endocr Dev; 2013; 24():33-40. PubMed ID: 23392093 [TBL] [Abstract][Full Text] [Related]